|
Manufacturing review: a manufacturing review was not required as this is the only complaint reported to date for this product and lot.Investigation summary: only one device was involved in this reportable event at the user facility.Additional unused lot samples from the same lot/product catalog number were returned from the customer for evaluation and investigation of this event.The original sample was not returned for evaluation, but one sealed lot bard magnum biopsy needle was returned for evaluation.Since, no original sample was returned; one lot sample was returned the lot sample was opened and evaluated.On visual evaluation, the sample was sealed.It was noted that the stylet hub was from cavity 14 and the cannula hub was from cavity 14.There were no visual anomalies noted on the device.Further, functional testing was not performed due to the nature of the complaint.Upon dimensional observation, the notch thickness was measured, and the measurement was noted to be within specification.The reported event was unconfirmed for the evaluated lot sample, as there is no allegation was found.However, the investigation is inconclusive for the reported adverse event without identified device or use problem as the original device was not returned for evaluation only sealed lot sample was returned.A definitive root cause for the alleged adverse event without identified device or use problem could not be determined based upon the provided information.Labeling review: a review of product labeling documentation (e.G., procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) did not find any product labeling inadequacy.(expiry date: 11/2024).The information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|
|
It was reported that during a prostate biopsy procedure through normal density tissue, the patient allegedly experienced bleeding.A coaxial was not used and the procedure was completed using another device.Right after the biopsy, a rectorrhagia occurred that did not subside and required the performance of a rectoscopy, in which a hemostatic injection of six cc of adrenaline was given and four clips were placed to control the bleeding.The patient was subsequently discharged after twenty-four hours of observation.
|